Adela gets $60m funding to advance DNA-based cancer detection
Adela claims that its technology can differentiate the most highly informative (methylated) regions of the genome from non-informative…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
24 Jun 21
Adela claims that its technology can differentiate the most highly informative (methylated) regions of the genome from non-informative…
23 Jun 21
The updated version of high-sensitive Covid-19 PCR kit is used to detect current and emerging viral mutations
21 Jun 21
The in vitro diagnostic test will help identify the presence of the RdRp and E genes of SARS-CoV-2…
21 Jun 21
Cobas SARS-CoV-2 Nucleic acid test is authorised for use in asymptomatic and symptomatic people, delivering results within 20…
18 Jun 21
Mobidiag’s Amplidiag and Novodiag testing platforms hold the potential to offer results in 50 minutes to two hours
18 Jun 21
Test can screen up to 5 individuals suspected of COVID-19 or up to 5 asymptomatic individuals
17 Jun 21
BBI Solutions offers a range of products, including antibodies, antigens, labels, complementary reagents and point of care tests
17 Jun 21
Curative is partnering with Abbott to implement the Alinity m Resp-4-Plex and SARS-CoV-2 assays across its laboratory network
15 Jun 21
The trial will assess the safety and efficacy of Seraph 100 blood purification therapy in critically ill patients…
15 Jun 21
The cPass Neutralisation Test Kit will help identify circulating neutralising antibodies against the receptor-binding domain (RBD) of the…